Remidio

Remidio

Private
Bangalore UrbanHealthcare & Life Scienceshttps://remidio.com

Last Round

Series B

Feb 18, 2023

Est. Valuation

$66.58M

Total Funding Raised

$19.34M

Company Overview

Remidio is a medical technology company that develops and manufactures AI-powered portable ophthalmic imaging devices designed to help diagnose eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Telemedicine, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

portable fundus cameradiabetic retinopathy screeningsmartphone fundus cameramedical AIophthalmic imagingMedTechretinal imagingoffline AIon-device AIpoint of care diagnosticstele-ophthalmologynon-mydriatic imagingedge AIglaucoma detectionAMD detectionportable slit lamphealth IoTFDA 510k clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remidio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Remidio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 18, 2023
VC RoundMar 31, 2022
GrantNov 18, 2020
Series BJan 14, 2016
AngelAug 28, 2015
Grant
Jan 1, 2012

Key People

Founding team and executive leadership

Anand Sivaraman

Chief Executive Officer, Director

Executive Team

Wilson D Souza

COO- Remidio India

Executive Team

Remidio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Recognized among top 3 in India's AI at the HER Challenge.

  • Feb 19, 2026

    Attended the India AI Impact Summit 2026 on February 19, 2026.

Remidio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Remidio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Remidio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore Urban
Employee Range207
Year Founded2009
Last FundingFeb 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.